{"disease":{"id":"cidp-chronic-inflammatory-demyelinating-polyneuropathy","name":"cidp chronic inflammatory demyelinating polyneuropathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04589299","title":"Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT07121985","title":"Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"University of Erlangen-Nürnberg Medical School","has_results":false},{"nct_id":"NCT05584631","title":"IVIG vs SCIG in CIDP","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT07343310","title":"A First-in-Patient Clinical Trial of KINE-101 in Patients With Corticosteroid-Refractory CIDP","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Kine Sciences Co., Ltd.","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}